Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
{{output}}
Objective: The objective of this paper is to evaluate potential dose-dependent adverse effects of gadolinium-based contrast agents (GBCAs) on MS progression. Meth... ...
